e. coli bacteria

Recurring UTIs: The Infection We Keep Secretly Getting

Want to pee all the time, or been told to drink cranberry juice because it burns when you pee? If so, you might have experience with urinary tract infections or UTIs. UTIs happen when certain types of bacteria get into part of your urinary tract, like your bladder, and create an infection. Researchers estimate that 60% of women and 10% of men will get a UTI in their lifetime.  Typically, people are told to avoid UTIs by bettering their personal hygiene—peeing before and after sex, wiping properly, ceasing douching—and drinking more water. Because of this, many people may feel ashamed or embarrassed when they get a UTI, thinking it was their fault. But about one in four women experience recurring UTIs, which is defined as having at least two infections in six months or three in a year. Even when these patients do everything right, they still get infections. Read more.

Source: NPR, September 6, 2023

business buildings

Caldera Medical Acquires Atlantic Therapeutics to Expand Portfolio in Women’s Health

Caldera Medical, a women’s health medical device company that develops and markets best-in-class products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, Polyps and Fibroids, announced today that it has completed its acquisition of Atlantic Therapeutics, an Ireland based provider of non-invasive pelvic floor strengthening and nerve stimulating solutions for women. The acquisition bolsters Caldera Medical’s expanding portfolio, furthering its mission to improve the quality of life for women! Read more.

Source: Business Wire, September 6, 2023

product approval introduction

BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

BlueWind Medical, Ltd. today announced that the US Food and Drug Administration (FDA) granted a De Novo marketing request for the Revi System, a transformative tibial neuromodulation therapy for the treatment of the symptoms of urgency incontinence alone or in combination with urinary urgency. Physicians should follow clinical guidelines as applicable and should use their discretion to determine if Revi can be used before patients fail or not tolerate more conservative therapy. The De Novo grant is for men and women with urge urinary incontinence (UUI) and was based on results from the OASIS pivotal trial, in which Revi demonstrated statistically significant improvement in the reduction of symptoms of UUI compared to baseline and a favorable safety profile. Read more.

Source: PRNewswire, August 17, 2023

nursing home patients

Incontinence Management: A Crisis In Plain Sight

I find often when trying to help providers improve their quality and operational performance metrics, most of the time they are overlooking or ignoring a major foundational concept. Two-thirds of the clinical pathways or critical elements that CMS has sent forth often involve the incontinence ecosystem (See Figure 1). Incontinence, as stated in some of my previous articles, needs to be taken seriously when trying to improve overall quality. Read more.

Source: McKnight’s Long Term Care News, August 9, 2023

Bacteria

Vaginal Estrogen Effective Against Recurrent UTIs

According to a recent study published in the American Journal of Obstetrics & Gynecology, vaginal estrogen is effective in preventing recurrent urinary tract infections (UTIs) in women with hypoestrogenism. Over 60% of women are impacted by UTIs in their lives, costing over $2 billion per year in the United States. Breakthrough infections even while on active antibiotic suppression are reported in 70% to 80% of recurrent UTI cases. Read more.

Source: Contemporary OB/GYN, August 10, 2023

Drug-coated Balloon Gets FDA Clearance for Treating Enlarged Prostate

Benign prostatic hyperplasia — or BPH, more commonly known as an enlarged prostate — is common among older men. As many as 30% of those aged 80 or more years have severe enough symptoms — including urinary incontinence — to require treatment.  One nonsurgical solution, balloon dilation, can be used to widen the urinary tract and has been around for several decades, but an innovative version of this tool recently received federal clearance and now is being used commercially. Read more.

Source: McKnight’s Senior Living, August 7, 2023

children pediatric classroom

New Muscle Therapy Gets Fast-Track Boost

To help bring therapies for rare muscle diseases in children to market sooner, the Berlin-based start-up MyoPax, a spin-off from the Max Delbrück Center and Charité – Universitätsmedizin Berlin, has now received a boost from the U.S. Food and Drug Administration (FDA). The company has been granted the FDA’s orphan drug designation (ODD) and rare pediatric disease designation (RPDD), both of which offer multiple regulatory and financial advantages – including fast-track approval status and, eventually, market exclusivity. Read more.

Source: Eurekalert, July 26, 2023

New Survey from Aeroflow Urology Reveals Over 70% of Consumers Struggle to Afford Diapers for Adults and Children

Aeroflow Urology, a nationwide provider of continence care supplies through insurance, announced today the results of a proprietary survey that demonstrates the divide in affordability for diapers and other incontinence products for low-income families in the United States. While legislation has been slowly passing in some states to improve access to diapers by removing taxation and other barriers, many Americans still struggle daily to afford these essential items for both children and adults. To gain a better understanding of the current gaps in affordability around diapers and the repercussions for those who cannot access these items, Aeroflow Urology conducted a third-party administered survey in April 2023 that polled more than 1,200 Americans with a single household income of $25,000 or double household income of $50,000 or less who care for someone needing diapers or incontinence supplies (i.e. kids, children and adults with disabilities, elderly, etc.). Read more.

Source: PRNewswire, July 11, 2023

Bladder & Tail Leaks

My Story – Submitted by Lisa

After 12 years of dialysis I got a kidney that I call Hannah. This month [June 2023] made 7 years that I had my transplant.  I haven’t passed urine in 4 years after the operation. I went often and I started to smell urine off and on with a little of wetness. With my bottom I developed hemorrhoids because when I was on dialysis your fluids are limited.  Not until later I found them leaking after every bowel movement orContinue reading

mother post pregnancy

Missed Opportunities For the One In Five With Anal Incontinence After Childbirth

Researchers are calling for improved care and more awareness of injuries that leave over one in five of those giving birth with anal incontinence. Over one in five women will develop anal incontinence in the first five years after having a vaginal birth. Anal incontinence is common and usually caused by trauma to the pelvic floor, nerve damage and anal sphincter injuries. The timing of symptom onset varies; some women experience anal incontinence onset soon after childbirth (which may or may not resolve), while many develop worsening or new symptoms during the menopause. The University of Warwick-led study, with input from the MASIC Foundation (a national charity to support women who have suffered severe injuries during childbirth), identified missed opportunities in getting a diagnosis of anal incontinence, an absence of clear pathways for those who are referred for treatment, and a lack of awareness of the problem among health care professionals and those who have given birth. Read more.

Source: MedicalXpress, June 28, 2023